Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Eyenovia Inc (EYEN)

Eyenovia Inc (EYEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 45,606
  • Shares Outstanding, K 2,883
  • Annual Sales, $ 60 K
  • Annual Income, $ -49,820 K
  • EBIT $ -30 M
  • EBITDA $ -28 M
  • 60-Month Beta 2.47
  • Price/Sales 534.08
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -24.79
  • Most Recent Earnings $-1.59 on 05/19/25
  • Next Earnings Date 08/11/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -14.40
  • Growth Rate Est. (year over year) +7,037.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.71 +825.15%
on 06/03/25
17.18 -7.92%
on 07/02/25
+14.15 (+847.31%)
since 06/02/25
3-Month
0.85 +1,761.18%
on 04/09/25
17.18 -7.92%
on 07/02/25
+14.64 (+1,240.68%)
since 04/02/25
52-Week
0.85 +1,761.18%
on 04/09/25
124.80 -87.32%
on 07/29/24
-43.60 (-73.38%)
since 07/02/24

Most Recent Stories

More News
Eyenovia Announces Rebranding and Corporate Name Change to Hyperion DeFi, Inc.

HYPD : 11.56 (+1.58%)
EYEN : 15.82 (+49.81%)
Eyenovia Adds $10 Million in HYPE to its Treasury Holdings in Preparation for Strategic Onchain Engagement

EYEN : 15.82 (+49.81%)
Small Cap News Movers: Your Daily Digest of Stocks Making Moves on Market News

The past week has seen a flurry of activity across various sectors, with several small- and mid-cap stocks delivering notable gains and drawing significant investor attention. From healthcare innovators...

WGS : 85.22 (-0.61%)
GEOS : 13.59 (-0.59%)
NNNN : 45.25 (+14.99%)
CDTX : 50.45 (+4.45%)
VERV : 11.13 (-0.27%)
EYEN : 15.82 (+49.81%)
Eyenovia Announces Co-Branded Validator with Kinetiq 

EYEN : 15.82 (+49.81%)
Eyenovia Announces Closing of $50 Million Private Placement, Successful Accumulation of More Than One Million HYPE Tokens, and Update on its Optejet Development Program

EYEN : 15.82 (+49.81%)
Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group

EYEN : 15.82 (+49.81%)
Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy

EYEN : 15.82 (+49.81%)
Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:OTLK),(NASDAQ:EYEN),(NYSE:BLCO),(NASDAQ:BMEA) EQNX::TICKER_END

OTLK : 1.8900 (+1.61%)
AVAI : 0.5660 (+6.87%)
BMEA : 1.8600 (+10.06%)
AMD : 137.82 (+2.24%)
BLCO : 14.00 (+1.38%)
EYEN : 15.82 (+49.81%)
Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities

OTLK : 1.8900 (+1.61%)
AVAI : 0.5660 (+6.87%)
BMEA : 1.8600 (+10.06%)
BLCO : 14.00 (+1.38%)
EYEN : 15.82 (+49.81%)
Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results

EYEN : 15.82 (+49.81%)

Business Summary

Eyenovia, Inc. is a clinical stage biopharmaceutical company which engages in developing therapeutics for the treatment of prominent eye diseases primarily in the United States. Its product portfolio includes MicroProst, MicroStat, MicroTears and MicroPine which are in clinical stage. Eyenovia, Inc....

See More

Key Turning Points

3rd Resistance Point 24.91
2nd Resistance Point 21.05
1st Resistance Point 18.43
Last Price 15.82
1st Support Level 11.95
2nd Support Level 8.09
3rd Support Level 5.47

See More

52-Week High 124.80
Fibonacci 61.8% 77.45
Fibonacci 50% 62.82
Fibonacci 38.2% 48.20
Last Price 15.82
52-Week Low 0.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar